CN103735885A - Otitis media treatment drug - Google Patents
Otitis media treatment drug Download PDFInfo
- Publication number
- CN103735885A CN103735885A CN201310650861.XA CN201310650861A CN103735885A CN 103735885 A CN103735885 A CN 103735885A CN 201310650861 A CN201310650861 A CN 201310650861A CN 103735885 A CN103735885 A CN 103735885A
- Authority
- CN
- China
- Prior art keywords
- otitis media
- media treatment
- treatment drug
- medicine
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an otitis media treatment drug, and belongs to the technical field of drugs. The otitis media treatment drug comprises 5-10 g of a corn starch paste, 5-10 g of magnesium stearate, 8-10 mg of weeping forsythia fruit, and 5-10 mg of levofloxacin hydrochloride. The otitis media treatment traditional Chinese medicine has advantages of no toxic-side effect, rapid onset and good treatment effect.
Description
technical field:
The invention belongs to field of pharmaceutical technology, particularly a kind of medicine that is used for the treatment of otitis media.
background technology:
At present, otitis media is kind of a commonly encountered diseases, and it is oral that medicine is mostly, and effect is bad.
summary of the invention:
The present invention is directed to the deficiencies in the prior art, a kind of medicine that is used for the treatment of otitis media is provided.
This medicine comprises: 5-10 grams of corn starch pastes, 5-10 grams of magnesium stearate, 8-10 milligrams of Fructus Forsythiaes, levofloxacin hydrochloride 5-10 milligram.
Advantage of the present invention: by Chinese crude drug heat-clearing and toxic substances removing, Western medicine antiinflammatory.
the specific embodiment:
The present invention describes by following examples:
This medicine comprises: 5-10 grams of corn starch pastes, 5-10 grams of magnesium stearate, 8-10 milligrams of Fructus Forsythiaes, levofloxacin hydrochloride 5-10 milligram.
Claims (1)
1. a medicine that is used for the treatment of otitis media, is characterized in that: this medicine comprises: 5-10 grams of corn starch pastes, 5-10 grams of magnesium stearate, 8-10 milligrams of Fructus Forsythiaes, levofloxacin hydrochloride 5-10 milligram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310650861.XA CN103735885A (en) | 2013-12-08 | 2013-12-08 | Otitis media treatment drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310650861.XA CN103735885A (en) | 2013-12-08 | 2013-12-08 | Otitis media treatment drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103735885A true CN103735885A (en) | 2014-04-23 |
Family
ID=50493001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310650861.XA Pending CN103735885A (en) | 2013-12-08 | 2013-12-08 | Otitis media treatment drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103735885A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111494489A (en) * | 2020-05-22 | 2020-08-07 | 华熙生物科技股份有限公司 | Gel sustained-release agent for treating otitis externa and preparation method thereof |
-
2013
- 2013-12-08 CN CN201310650861.XA patent/CN103735885A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111494489A (en) * | 2020-05-22 | 2020-08-07 | 华熙生物科技股份有限公司 | Gel sustained-release agent for treating otitis externa and preparation method thereof |
| CN111494489B (en) * | 2020-05-22 | 2022-08-26 | 华熙生物科技股份有限公司 | Gel sustained-release agent for treating otitis externa and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1893182B8 (en) | Oral dosage forms comprising progesterone and method of making and using the same | |
| WO2015034678A3 (en) | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis | |
| JP2014511393A5 (en) | ||
| WO2011104652A3 (en) | Veterinary compositions | |
| TW200700062A (en) | Pharmaceutical compositions | |
| PH12014501408A1 (en) | Immediate release multi unit pellet system | |
| WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| WO2015065546A3 (en) | Abuse-deterrent dosage forms | |
| WO2010012459A3 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms | |
| TN2011000307A1 (en) | Galenic formulation of organic compounds | |
| GB2455875B (en) | A process for the preparation of an orally administered unit dose tablet | |
| PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| WO2012040082A3 (en) | Antidiabetic solid pharmaceutical compositions | |
| WO2015028875A8 (en) | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir | |
| IN2015DN02999A (en) | ||
| CN103735885A (en) | Otitis media treatment drug | |
| MX2017015322A (en) | Oral pharmaceutical composition of isotretinoin. | |
| WO2014125504A3 (en) | Pharmaceutical compositions of febuxostat | |
| GB0920721D0 (en) | An orally administered anthelmintic unit dose tablet and process for the preparation thereof | |
| WO2015166419A3 (en) | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain | |
| CN105708864A (en) | Asthenopia treatment drug | |
| SG10201803996WA (en) | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation | |
| WO2012141615A3 (en) | Medicament | |
| GB0703674D0 (en) | A Process For The Preparation of an Orally Administered Unit Dose Tablet | |
| EP4052699A4 (en) | Orally administered solid dosage form drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140423 |